Triastek products

The 3DμS-MR platform represents a significant advancement in drug delivery technology, specifically designed to meet challenging pharmaceutical requirements. It is characterized by its ability to optimize the release behavior of drugs in vivo through intricate structural designs enabled by material science. This platform is instrumental in accelerating the research and development process by offering a versatile environment for the development of complex drug formulations. 3DμS®-MR's unique structure allows for the fine-tuning of drug release rates, enhancing the bioavailability of challenging molecules and improving overall drug efficacy. The released 3DμS®-MR V2.0 version expands its application scenarios, facilitating drug product design and development to an even greater extent, while the forthcoming V3.0 version is expected to address critical clinical needs, making it suitable for various new application scenarios. The ultimate aim is to increase productivity in the pharmaceutical industry by offering a robust solution to drug delivery issues.

The 3D Microstructure for Colon Targeting, or 3DμS®-CT, by TRIASTEK, is an advanced technology focused on the precision delivery of pharmaceutical compounds to the colon. This platform utilizes 3D printing techniques to create prototypes that encompass multiple release control mechanisms tailored to time and pH requirements. By doing so, it effectively navigates the challenges posed by individual gastrointestinal variance, ensuring localized efficacy and systemic absorption where needed. This capability is critical in reducing undesirable side effects and enhancing therapeutic outcomes by ensuring that the active compounds reach their intended site of action within the colon. Furthermore, the precise delivery mechanisms are coupled with robust image tracking technology, optimizing research and development efficiency and hence, expediting the drug development process. The 3DμS®-CT platform highlights the versatile applications of 3D microstructured products in addressing complex delivery challenges within the pharmaceutical industry.

Triastek's 3DuS-GR technology is designed for targeted drug delivery to the stomach, allowing the product to remain in the gastric region for a pre-determined duration. This system is capable of customizing drug release profiles to achieve either extended-release or pulsatile-release, thereby potentially enhancing the absorption of active pharmaceutical ingredients and increasing drug efficacy. The sustained presence in the upper gastrointestinal tract can lead to better oral bioavailability. Furthermore, the 3DμS®-GR system simplifies dosing regimens and improves clinical efficacy, while ensuring medication safety. The platform is backed by image tracking technology, contributing to accurate monitoring and administration. These features together aim to streamline treatment protocols in clinical environments.